AU2003268688A1 - Method of inducing immune responses - Google Patents

Method of inducing immune responses

Info

Publication number
AU2003268688A1
AU2003268688A1 AU2003268688A AU2003268688A AU2003268688A1 AU 2003268688 A1 AU2003268688 A1 AU 2003268688A1 AU 2003268688 A AU2003268688 A AU 2003268688A AU 2003268688 A AU2003268688 A AU 2003268688A AU 2003268688 A1 AU2003268688 A1 AU 2003268688A1
Authority
AU
Australia
Prior art keywords
immune responses
inducing immune
inducing
responses
immune
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003268688A
Inventor
Kiyo Nakanishi
Shigeo Takemura
Yuuki Tsutsui
Shunsuke Watanabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamanouchi Pharmaceutical Co Ltd
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Publication of AU2003268688A1 publication Critical patent/AU2003268688A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
AU2003268688A 2002-09-30 2003-09-29 Method of inducing immune responses Abandoned AU2003268688A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41502602P 2002-09-30 2002-09-30
US60/415,026 2002-09-30
PCT/JP2003/012420 WO2004028561A1 (en) 2002-09-30 2003-09-29 Method of inducing immune responses

Publications (1)

Publication Number Publication Date
AU2003268688A1 true AU2003268688A1 (en) 2004-04-19

Family

ID=32043418

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003268688A Abandoned AU2003268688A1 (en) 2002-09-30 2003-09-29 Method of inducing immune responses

Country Status (3)

Country Link
JP (1) JPWO2004028561A1 (en)
AU (1) AU2003268688A1 (en)
WO (1) WO2004028561A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6014666B2 (en) 2012-06-20 2016-10-25 国立大学法人 東京大学 Mucosal immune stimulating agent and oral pharmaceutical composition for treating HPV infection
US10206985B2 (en) 2013-02-05 2019-02-19 Nitto Denko Corporation WT1 peptide cancer vaccine composition for mucosal administration

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2052503T3 (en) * 1986-03-17 1994-07-16 Boehringer Ingelheim Int IMPROVEMENTS INTRODUCED IN VACCINES.
GB9326174D0 (en) * 1993-12-22 1994-02-23 Biocine Sclavo Mucosal adjuvant
IT1297090B1 (en) * 1997-12-01 1999-08-03 Barbara Ensoli TAT OF HIV-1 OR ITS DERIVATIVES, ALONE OR IN COMBINATION, FOR VACCINAL, PROPHYLACTIC AND THERAPEUTIC PURPOSES, AGAINST AIDS, CANCERS AND
CA2333854A1 (en) * 1998-07-27 2000-02-10 University Of Iowa Research Foundation Stereoisomers of cpg oligonucleotides and related methods
US6270758B1 (en) * 1998-10-08 2001-08-07 Duke University Substantially non-toxic biologically active mucosal adjuvants in vertebrate subjects
SI1031347T1 (en) * 1999-01-27 2002-10-31 Idea Ag Transnasal transport/immunisation with highly adaptable carriers
CN100340290C (en) * 1999-11-10 2007-10-03 宝德杰克特疫苗有限公司 Induction of mucosal immunity by vaccination via skin nute
AU2002249852A1 (en) * 2000-11-09 2002-08-12 Board Of Trustees Of The University Of Illinois Enhancement of immune response to vaccine by interferon alpha

Also Published As

Publication number Publication date
JPWO2004028561A1 (en) 2006-01-19
WO2004028561A1 (en) 2004-04-08

Similar Documents

Publication Publication Date Title
AU2003216363A1 (en) Massager and method of using same
AU2002351535A1 (en) Method of distance learning
AU2002242085A1 (en) Methods and compositions useful for stimulating an immune response
AU2002232447A1 (en) Method of enhancing lymphocyte-mediated immune responses
AU2003299823A1 (en) Methods of inducing and maintaining immune tolerance
AU2003277596A1 (en) Method of deuterization
AUPS160602A0 (en) Therapeutic method
AU2002246950A1 (en) Hydrocapsules and method of preparation
AU2003230004A1 (en) Methods of therapy for inducing tolerance
AU2003225710A1 (en) Composition and method for enhancing immune response
AU2003268688A1 (en) Method of inducing immune responses
EP1485124A4 (en) Method of inducing an enhanced immune response against hiv
AU2003288762A1 (en) Method and apparatus of hemorheometer
AU2002338571A1 (en) Compositions and methods for suppressing immune responses
AU2002366026A1 (en) Frying method
AU2002354363A1 (en) Method of activating protein
AU2002951913A0 (en) Method of treatment
AU2003259377A1 (en) Method of forming pocketted springs
AU2003276825A1 (en) Method of immunotherapy
AU2002249491A1 (en) Method of transesterification of fat or analogue
AU2002241324A1 (en) Fat producing method
AU2003212475A1 (en) Immune response associated proteins
AU2003268230A1 (en) Immune response associated proteins
AU2003290512A1 (en) Method of weldbonding
AUPS289002A0 (en) Egg cooking method and apparatus

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase